RESEARCH
Grounded in Evidence. Committed to Rigorous Science.
CCDI™ is being developed with a commitment to evidence-based methodology. Our research agenda spans clinical outcomes, interoperability standards, regulatory science, and real-world evidence generation in the medical cannabinoid space.
Development Status
CCDI™ is currently in development. Research publications, clinical data, and outcomes reports will be published here as the platform matures and data collection begins.
Research Philosophy
Evidence Informs. Clinicians and Patients Decide.
The CCDI™ platform is built on a foundational commitment to evidence-based practice. We do not prescribe, diagnose, or recommend. We build the infrastructure that makes evidence accessible, interpretable, and actionable at the point of care. Every design decision, data model, and integration standard is evaluated against this principle.
Methodological Rigor
Research conducted through or in partnership with CCDI™ will adhere to established clinical research standards, including peer review, transparent methodology, and reproducible findings.
Real-World Evidence
Our primary research focus is real-world evidence generation - capturing outcomes data from actual clinical and program contexts rather than controlled settings alone.
Interdisciplinary Collaboration
Meaningful research in this space requires collaboration across clinical medicine, pharmacology, health informatics, regulatory science, and public health. CCDI™ is designed to support that collaboration.
Transparency and Open Science
Where possible, CCDI™ research outputs will be published in open-access formats and data will be made available to the broader research community under appropriate data governance frameworks.
Research Agenda
Four Priority Research Areas.
Clinical Outcomes Research
Developing methodologies for collecting, analyzing, and applying real-world patient outcomes data across medical cannabinoid programs. This includes condition-specific outcomes frameworks, patient-reported outcome measures, and longitudinal tracking protocols.
Current Activities
- Outcomes framework design for priority conditions
- Patient-reported outcome measure selection and validation
- Longitudinal data collection protocol development
- Real-world evidence methodology standards
Interoperability and Data Standards
Advancing data standards and interoperability frameworks for cannabinoid clinical data exchange across healthcare and regulatory systems. This includes HL7 FHIR profile development, terminology mapping, and cross-system data governance.
Current Activities
- HL7 FHIR profile development for cannabinoid clinical data
- Terminology and coding standards mapping
- Cross-system data governance framework design
- EHR integration standards and API specifications
Regulatory Science
Supporting evidence-based approaches to state and federal regulatory frameworks for medical cannabinoid programs. This includes program evaluation methodology, compliance data infrastructure, and policy-relevant research outputs.
Current Activities
- State program evaluation methodology development
- Compliance and reporting data infrastructure design
- Federal rescheduling impact analysis frameworks
- Policy-relevant evidence synthesis and publication
Drug Interaction and Safety Research
Building and maintaining the evidence base for cannabinoid-drug interactions, contraindications, and safety signals. This includes systematic literature review, pharmacokinetic data synthesis, and clinical safety signal monitoring.
Current Activities
- Systematic literature review of cannabinoid-drug interactions
- Pharmacokinetic data synthesis and modeling
- Clinical safety signal monitoring framework
- Contraindication database development and maintenance
Publications
Research Publications
CCDI™ is in development. Peer-reviewed publications, white papers, and clinical data reports will appear here as research is completed and submitted for publication. We anticipate initial publications in 2025-2026.
Peer-Reviewed Research
Original research articles submitted to and published in peer-reviewed clinical and health informatics journals.
Forthcoming
White Papers
Policy-relevant white papers on regulatory science, data standards, and program design in the medical cannabinoid space.
Forthcoming
Clinical Data Reports
Outcomes data reports and real-world evidence summaries generated from CCDI™ platform data as the platform matures.
Forthcoming
Technical Standards
Published technical specifications, FHIR profiles, and interoperability standards developed through the CCDI™ research program.
Forthcoming
Research Partnerships
We Are Actively Seeking Research Partners.
CCDI™ is designed to support collaborative research across academic medical centers, clinical research organizations, health systems, and public health institutions. If your organization is conducting or planning research in the medical cannabinoid space, we want to hear from you.
Discuss a Research PartnershipAcademic Medical Centers
Clinical research partnerships with academic medical centers conducting cannabinoid therapeutics research.
Clinical Research Organizations
CRO partnerships to support outcomes data collection, protocol development, and real-world evidence generation.
Public Health Institutions
Collaboration with schools of public health and public health agencies on program evaluation and population-level outcomes research.
Health Informatics Programs
Research partnerships with health informatics programs on interoperability standards, data governance, and clinical decision support methodology.